We are a European AI-Biotech company - building an Agentic Platform, and more - to engineer health solutions.
Our mission is to bring greater insight to the most complex challenges in healthcare. We are working towards a future where diseases are better understood, patients receive more precise care, and prevention advances alongside treatment.
The World Health Organization (WHO) remains firmly committed to the principles set forth in the preamble to its Constitution, especially its definition of human health. According to the WHO, health is "a state of complete physical, mental, and social well-being, and not merely the absence of disease or infirmity."
This universal vision of health inspires us: it reminds us that well-being goes beyond the absence of illness. It is an ideal to be cultivated, a delicate balance of body, mind, and society - one that science and innovation must help protect and strengthen.
Heterogeneous multi-modal and temporal data, microbiota complex interactions, patient pathway, pharmacological modulator research and discovery
Explainable AI models, predictive computational methods, specialised autonomous agents, knowledge graph and bioinformatics data engineering
Could the cure for diseases already be living inside us?
Our engine - an Agentic AI Biotech Platform - orchestrates heterogeneous data, advanced computational methods, and autonomous agents to accelerate discovery of innovative health solutions.
Our platform consolidates massive biological and clinical datasets into a unified, federated resource. This singular database breaks down silos, unlocks cross-disciplinary insights, and reveals hidden connections that accelerate discovery and fuel advanced data analysis.
We harness the power of our specialised autonomous scientific agents - AI systems capable of reasoning, learning, and acting across complex biological landscapes. These agents accelerate discovery, optimize experimentation, and continuously adapt to emerging scientific insights.
We explore the microbiome as both a driver and a target of health, with a particular focus on pharmaco microbiomics - the interactions between drugs and microbial ecosystems. We aim to unlock new therapeutic avenues and optimize treatment responses.
Our research combines holistic systems-level perspectives with deep mechanistic precision. We seek to understand biology not only as an integrated whole but also at the molecular and cellular levels, bridging complexity with clarity: through mecanistic modeling.
As scientists at heart, we choose to lead through innovation, reshaping healthcare and positioning ourselves to become a leading force in Europe by 2030.
CEO
CSO
CTO & COO
"Our mission is audacious - to redefine the boundaries of science, medicine, and technology - for the benefit of humanity. It requires more than passion, it's about the relentless pursuit of breakthroughs, fueled by creativity, collaboration, and unwavering integrity. We're not just pushing boundaries; we want to build the future of healthcare, one innovation at a time."
Our team brings together 41 years of complementary expertise spanning AI, data engineering, bioinformatics, biotechnology, drug discovery, and clinical research.
We harness AI to transform your complex data into actionable knowledge. Our expertise in predictive models, multimodal integration, and automation accelerates discovery and innovation.
We design next-generation bioinformatics pipelines to unlock the value of your biological and biomedical data. From omics to imaging, our expertise turns complex datasets into reliable and impactful insights.
We provide cross-cutting expertise to support every stage of your projects. From strategy and infrastructure to training and collaboration, we ensure reproducibility, efficiency, and long-term impact.
We cover the full data value chain, from proof of concept to large-scale research and discovery programs. We adapt our expertise to your needs.
Flexible, modular expertise to fit your specific challenges and goals.
We drive strategic, high-impact scientific collaborations with clinicians, research institutes, CROs, pharma, agrifood, and cosmetic companies.
Thanks to our partners and supporters.
Sagacity Health has been officially established in 2025. Our company operates at the intersection of AI and biotechnology. Our objective is to contribute to progress in healthcare.
We has been selected as a laureate of the OncoEntrepreneur program by Paris Saclay Cancer Cluster (PSCC) in pre-creation. This program supports promising projects driving progress in cancer.
Like every great journey, Sagacity Health is above all a story of women and men united by a vision, a clear strategy, rigorous execution, and a genuine commitment.
Sharp understanding of the hardest things
We built our expertise at the heart of the pharmaceutical and biotechnology industry. Today, we aspire to improve health as a whole through our vision, powered by innovation, collaboration, and sagacity.
In healthcare, sagacity refers to the ability of a professional (doctor, nurse, researcher) to combine clinical intuition, experience and critical reasoning to reach an accurate diagnosis, anticipate complications or develop and make appropriate therapeutic decisions, even in complex or uncertain situations.
Our guiding motto captures both the complexity of today's medical challenges and the precision of the mindset we bring. Sharp understanding is not just a skill - it is our commitment to clarity, rigor, and actionable insight at every level - from data and knowledge - to human and patient outcomes.
English, French
French, Belgian, Luxembourg
Alone we move fast, together we go beyond.